OptimizeRx logo

OptimizeRxNASDAQ: OPRX

Profile

Sector:

Healthcare

Country:

United States

IPO:

28 November 2007

Next earnings report:

28 March 2025

Last dividends:

N/A

Next dividends:

N/A
$81.42 M
-93%vs. 3y high
42%vs. sector
-vs. 3y high
-vs. sector
-92%vs. 3y high
32%vs. sector
-95%vs. 3y high
22%vs. sector

Price

after hours | Wed, 20 Nov 2024 21:02:14 GMT
$4.42+$0.14(+3.27%)

Dividend

No data over the past 3 years
$21.31 M$29.54 M
$21.31 M-$9.12 M

Analysts recommendations

Institutional Ownership

OPRX Latest News

OptimizeRx (OPRX) Moves 5.4% Higher: Will This Strength Last?
zacks.com03 October 2024 Sentiment: NEUTRAL

OptimizeRx (OPRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences
globenewswire.com09 September 2024 Sentiment: POSITIVE

The availability of Micro-Neighborhood ® Targeting on the Company's Dynamic Audience Activation Platform meets the demand of life sciences marketers by synchronizing consumer and physician marketing

OptimizeRx Corp. (OPRX) Tops Q2 Earnings Estimates
zacks.com08 August 2024 Sentiment: POSITIVE

OptimizeRx Corp. (OPRX) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to loss of $0.01 per share a year ago.

OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET
globenewswire.com25 July 2024 Sentiment: POSITIVE

WALTHAM, Mass., July 25, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, will hold a conference call on Thursday, August 8, 2024, at 4:30 p.m. Eastern Time to discuss its results for the second quarter period ended June 30, 2024. The financial results will be issued in a press release prior to the call.

OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients
globenewswire.com15 July 2024 Sentiment: POSITIVE

The Company's AI-guided predictive targeting platform delivered three times the return in half the time of the traditional trigger-based program The Company's AI-guided predictive targeting platform delivered three times the return in half the time of the traditional trigger-based program

OptimizeRx Corporation (OPRX) Q1 2024 Earnings Call Transcript
Seeking Alpha14 May 2024 Sentiment: POSITIVE

OptimizeRx Corporation (NASDAQ:OPRX) Q1 2024 Earnings Conference Call on May 14, 2024 at 2:30 PM ET with Company Participants including CEO William Febbo, CFO Edward Stelmakh, President Steve Silvestro, and SVP of Corporate Finance Andrew D'Silva. Various conference call participants are also present. Thank you for joining the discussion on OptimizeRx's First Quarter Fiscal 2024 Earnings.

Does OptimizeRx (OPRX) Have the Potential to Rally 34.78% as Wall Street Analysts Expect?
Zacks Investment Research13 May 2024 Sentiment: POSITIVE

The average price target suggests a potential 34.8% increase for OptimizeRx (OPRX). Although studies show this metric may not always be accurate, an increase in earnings estimates could indicate a positive outlook for the stock in the short term.

OptimizeRx to Participate in Upcoming Investor Conferences
GlobeNewsWire06 May 2024 Sentiment: NEUTRAL

WALTHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a top provider of healthcare technology solutions assisting life sciences companies in connecting with healthcare professionals (HCPs) and patients, disclosed today that its management will be attending the following upcoming investor conferences:

OptimizeRx to Participate in Upcoming Investor Conferences
GlobeNewsWire21 February 2024 Sentiment: NEUTRAL

WALTHAM, Mass., Feb. 21, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that management will participate in the following upcoming investor conferences:

OptimizeRx Corp. (OPRX) Upgraded to Buy: What Does It Mean for the Stock?
Zacks Investment Research11 December 2023 Sentiment: POSITIVE

OptimizeRx Corp. (OPRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

What type of business is OptimizeRx?

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

What sector is OptimizeRx in?

OptimizeRx is in the Healthcare sector

What industry is OptimizeRx in?

OptimizeRx is in the Health Information Services industry

What country is OptimizeRx from?

OptimizeRx is headquartered in United States

When did OptimizeRx go public?

OptimizeRx initial public offering (IPO) was on 28 November 2007

What is OptimizeRx website?

https://www.optimizerx.com

Is OptimizeRx in the S&P 500?

No, OptimizeRx is not included in the S&P 500 index

Is OptimizeRx in the NASDAQ 100?

No, OptimizeRx is not included in the NASDAQ 100 index

Is OptimizeRx in the Dow Jones?

No, OptimizeRx is not included in the Dow Jones index

When was OptimizeRx the previous earnings report?

No data

When does OptimizeRx earnings report?

The next expected earnings date for OptimizeRx is 28 March 2025